Late side effects of high-dose steroid therapy on skeletal system in children with idiopathic thrombocytopenic purpura

Journal of Pediatric Hematology/Oncology

Volumn 30, Issue 10, 2008, Pages 749-753

  Yldrm, Zühal Keskin ^a   Büyükavc, Mustafa ^a   Eren, Suat ^a   Orbak, Zerrin ^a   Şahin, Ali ^a   Karakelleoǧlu, Cahit ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Bone turnover; Childhood; High dose corticosteroid; Idiopathic thrombocytopenic purpura

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CREATININE; DEOXYPYRIDINOLINE; METHYLPREDNISOLONE; PARATHYROID HORMONE; PHOSPHATE; BIOLOGICAL MARKER; CORTICOSTEROID;

ADOLESCENT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE NECROSIS; CALCIUM URINE LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DRUG MEGADOSE; FEMALE; FEMUR HEAD; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; BONE; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; FOLLOW UP;

ADOLESCENT; ADRENAL CORTEX HORMONES; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CASE-CONTROL STUDIES; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METHYLPREDNISOLONE; OSTEONECROSIS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 58149229667     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e318180bbc9     Document Type: Article

References (26)

1. British Committee for Standards in Haematology General Haema-tology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol. 2003;120:574-596.
2. Karpatkin S. Autoimmune (idiopathic) thrombocytopenic purpura. Lancet. 1997;349:1531-1536.
3. Blanchette VS, Carcao M. Childhood acute immune thrombo-cytopenic purpura: 20 years later. Semin Thromb Hemost. 2003;29: 605-617.
4. Duru F, Fisgin T, Yarali N, et al. Clinical course of children with immune thrombocytopenic purpura treated with intravenous immunoglobulin G or megadose methylprednisolone or observed without therapy. Pediatr Hematol Oncol. 2002;19:219-225.
5. Albayrak D, İcşlek İ, Kalayci AG, et al. Acute immune thrombo-cytopenic purpura: a comparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin. J Pediatr. 1994;125:1004-1007.
6. Dilber C, Daǧdemir A, Albayrak D, et al. Reduced bone mineral density in childhood chronic idiopathic thrombocytopenic purpura treated with high-dose methylprednisolone. Bone. 2004;35:306-311.
7. Gulati S, Godbole M, Singh U, et al. Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease? Am J Kidney Dis. 2003;41:1163-1169.
8. Hougardy DM, Peterson GM, Bleasel MD, et al. Is enough attention being given to the adverse effects of corticosteroid therapy? J Clin Pharm Ther. 2000;25:227-234.
9. Liu AH, Spahn JD, Leung DYM. Childhood asthma. In: Berhman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics. 16th ed. Philadelphia: WB Saunders; 2004:760-773.
10. Compston J. Glucocorticoid-induced osteoporosis. Horm Res. 2003; 60:77-79.
11. Fujita T, Satomura A, Hidaka M, et al. Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy. Calcif Tissue Int. 2000;66:195-199.
12. Siomou E, Challa A, Tzoufi M, et al. Biochemical markers of bone metabolism in infants and children under intravenous corticosteroid therapy. Calcif Tissue Int. 2003;73:319-325.
13. American College of Rheumatology Ad Hoc Committee on Glucocorticoid- Induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum. 2001;44:1496-1503.
14. Garnero P, Delmas PD. Biochemical markers of bone turnover. Applications for osteoporosis. Endocrinol Metab Clin North America. 1998;27:303-323.
15. Impach P. Immune Thrombocytopenic Purpura. In: Lilleyman J, Hann I, Blanchette V, eds. Pediatric Hematology. 2nd ed. NY: Churchill Livingstone; 2000:437-447.
16. Reid IR. Glucocorticoid osteoporosis-mechanisms and management. Eur J Endocrinol. 1997;137:209-217.
17. Mazziotti G, Giustina A, Canalis E, et al. Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects. Arq Bras Endocrinol Metabol. 2007;51:1404-1412.
18. Lukert BP. Glucocorticoid-induced osteoporosis. In: Favus MJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 1999:292-295.
19. Habib GS, Haj S. Bone mineral density in patients with early rheumatoid arthritis treated with corticosteroids. Clin Rheumatol. 2005;24:129-133.
20. Matsumoto H, Ishihara K, Hasegawa T, et al. Effects of inhaled corticosteroid and short courses of oral corticosteroids on bone mineral density in asthmatic patients: a 4-year longitudinal study. Chest. 2001;120:1468-1473.
21. Ojala AE, Paakko E, Lanning FP, et al. Osteonecrosis during the treatment childhood acute lymphoblastic leukemia: a prospective MRI study. Med Pediatr Oncol. 1999;32:11-17.
22. Murphy RG, Greenberg ML. Osteonecrosis in pediatric patients with acute lymphoblastic leukemia. Cancer. 1990;65:1717-1721.
23. Fordyce MJ, Solomon L. Early detection of avascular necrosis of the femoral head by MRI. Bone Joint Surg Br. 1993;75:365-367.
24. Felsen DT, Anderson JJ. Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet. 1987;18:902-905.
25. Zanetti M, Romero J, Dambacher MA, et al. Osteonecrosis diagnosed on MR images of the knee. Relationship to reduced bone mineral density determined by high resolution peripheral quantitative CT. Acta Radiol. 2003;44:525-531.
26. Kaste SC, Shidler TJ, Tong X, et al. Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant. 2004;33:435-441.